Skip to main content
Caplight Logo









Scaffold Biotech

Scaffold Biotech

Private
MontevideoHealthcare & Life Scienceshttps://scaffoldbiotech.com/

Last Round

Seed

Feb 1, 2024

Total Funding Raised

$750,000

Company Overview

Scaffold Biotech is a biotechnology company that develops next-generation subunit vaccines for animal health using protein engineering and artificial intelligence.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Government Contracts, Services & Consulting

AI Layer

Application

Keywords

subunit vaccinenanovaccineprotein engineeringanimal healthveterinary biotechrational vaccine designbovine healthtick controlbioinformaticsin-silico designagtechvaccine developmentlivestock medicinedrug discoveryclinical trials

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Scaffold Biotech Comparables

Compare Scaffold Biotech with similar companies based on industry and business-model similarity.

Scaffold Biotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Genvax Technologies
79%
ArkVax
74%
Merck & Co., Inc.
63%

Scaffold Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedFeb 1, 2024

Key People

Founding team and executive leadership

Agustin Correa

Chief Executive Officer

Executive Team

Scaffold Biotech Investors

Notable investors and investment history

Scaffold Biotech investors
InvestorRounds
LAB+ Company BuilderSeed
Agencia Nacional de Investigación e InnovaciónSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 1, 2024

    $750K round led by LAB+ Company Builder

Scaffold Biotech Filings

Explore SEC and related filing metadata, where available.

Scaffold Biotech filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Scaffold Biotech's valuation, stock price, and market status.

Is Scaffold Biotech a public or private company?

Scaffold Biotech is a private company.

What is the current stock price of Scaffold Biotech?

Scaffold Biotech is a private company with no public stock price. No recent secondary market data is available.

How much is Scaffold Biotech worth (valuation)?

Valuation information for Scaffold Biotech is not publicly available.

Can I buy Scaffold Biotech stock?

Scaffold Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Scaffold Biotech's last funding round?

Scaffold Biotech's most recent funding round was Seed on February 1, 2024.

Who are the main investors in Scaffold Biotech?

Key investors in Scaffold Biotech include LAB+ Company Builder.

Will Scaffold Biotech IPO soon?

No public IPO plans have been announced for Scaffold Biotech.

How can I track Scaffold Biotech secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Scaffold Biotech's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMontevideo
Employee Range6
Year Founded2021
Last FundingFeb 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?